Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | MAP3K9 | P80192 | 3/20 | 0.49 |
| ▸ | MAP3K11 | Q16584 | 3/20 | 0.49 |
| ▸ | CDK4 | P11802 | 3/20 | 0.49 |
| ▸ | CCND1 | P24385 | 3/20 | 0.49 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.49 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.49 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.49 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.49 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.49 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.49 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.47 |
| ▸ | MAP3K10 | Q02779 | 1/20 | 0.47 |
| ▸ | TNKS | O95271 | 1/20 | 0.47 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 3/20 | 0.42 |
| ▸ | KRAS | P01116 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19988475 | 0.93 | MEN1 (0.53) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL24767906 | 0.89 | GABRA1 (0.49) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL19988607 | 0.89 | MAP3K9 (0.55) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL19988477 | 0.85 | GABRA1 (0.46) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL24768257 | 0.84 | GABRA1 (0.52) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL19988789 | 0.80 | GABRA1 (0.53) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL23353333 | 0.80 | TNKS (0.67) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL16751658 | 0.79 | GABRA1 (0.51) | MEN1MAPTRAB9AKMT2ACDK4 | |
| SCHEMBL15318798 | 0.78 | GABRA1 (0.48) | MEN1MAPTRAB9AKMT2AMAP3K9 | |
| SCHEMBL19988629 | 0.77 | MEN1 (0.45) | MEN1MAPTRAB9AKMT2AMAP3K9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3512848-B1 | COMPOUNDS WITH CARBAZOLE STRUCTURES | MERCK PATENT GMBH (DE) | 2020-11-18 | — | — | EP | disclosed |
| US-20190214574-A1 | COMPOUNDS WITH CARBAZOLE STRUCTURES | MERCK PATENT GMBH (DE) | 2019-07-11 | — | — | US | disclosed |
| WO-2018050583-A1 | COMPOUNDS WITH CARBAZOLE STRUCTURES | MERCK PATENT GMBH (DE) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190214574-A1 | COMPOUNDS WITH CARBAZOLE STRUCTURES | CYCS, CYP3A4, CYP2E1 | MEN1 3510/4885MAPT 2010/4885RAB9A 2257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.